An increased risk of pharyngeal cancer has been reported previously by Van Asperen et al. [11] for BRCA2 GPV carriers and their untested first-degree relatives, with follow-up until the age of 80 years [RR 7.30, 95%CI 1.66–32.01]. The gene discussed is BRCA2; the disease is pharynx cancer.